Prof. Fang Li | Gynecology| Excellence in Innovation Award

Prof. Fang Li ,Oriental Hospital Affiliated to Tongji University, China

Dr. Fang Li is a distinguished gynecologic oncologist, academic leader, and professor at Tongji University’s Shanghai East Hospital. With over 20 years of clinical experience, he specializes in diagnosing and treating cervical precancerous lesions and gynecologic tumors, utilizing laparoscopic, robotic, and open surgeries. A graduate of Tongji Medical College, he has conducted groundbreaking research on high-risk HPV and its role in cervical cancer. His innovative contributions include establishing an HPV16 evolutionary tree and developing an in vivo microendoscopic pathological diagnosis system. As a visiting scholar at the University of Cambridge, he advanced research in gynecologic oncology. His work, widely published in high-impact journals, has significantly influenced precision treatment and immunotherapy strategies for cervical cancer.

🌍 Professional Profile:

Scopus

🏆 Suitability for the Excellence in Innovation Award

Dr. Fang Li’s pioneering research in gynecologic oncology makes him an ideal candidate for the Excellence in Innovation Award. His discoveries on high-risk HPV integration and single-cell tumor microenvironment analysis have revolutionized cervical cancer diagnostics and treatment. His innovative development of a microendoscopic in vivo pathological diagnosis system enhances real-time cervical cancer detection, advancing precision medicine. His translational research has led to novel immunotherapy strategies, improving patient outcomes. A leader in clinical application and academic research, he has published extensively in high-impact journals, influencing global gynecologic oncology practices. His work exemplifies groundbreaking innovation with direct clinical impact, improving women’s health worldwide through early detection and targeted therapy advancements.

🎓 Education 

Dr. Fang Li earned his M.D. and Ph.D. in Obstetrics and Gynecology from Tongji Medical College of Huazhong University of Science and Technology under the mentorship of Academician Ma Ding. With a strong foundation in gynecologic oncology, he has pursued specialized training and research in high-risk HPV and cervical cancer pathogenesis. As a China Scholarship Council-sponsored visiting scholar, he conducted advanced research at the University of Cambridge’s Department of Genetics and the Gynecologic Oncology and Endoscopy Center at Addenbrooke’s Hospital. His academic training, enriched by global exposure and cutting-edge research, has shaped his expertise in precision oncology, immunotherapy, and minimally invasive surgical techniques, making him a leader in gynecologic cancer research and treatment.

🏢 Work Experience 

Since 2005, Dr. Fang Li has been actively engaged in clinical, teaching, and research work at the Affiliated Hospital of Tongji University. In 2019, he joined Shanghai East Hospital, where he serves as the Director of Gynecological Oncology. His expertise spans over 20 years, specializing in cervical precancerous lesions, cervical cancer, and gynecologic tumor management. He is proficient in advanced surgical techniques, including laparoscopic, robotic, and single-port procedures. His experience also includes international research collaborations at the University of Cambridge, where he investigated HPV-related carcinogenesis. With a patient-first approach, he has treated nearly 200,000 gynecological patients, earning their trust and recognition. His leadership in oncology research and clinical innovation continues to shape modern gynecologic cancer treatment.

🏅 Awards and Honors 

Dr. Fang Li has received numerous accolades for his contributions to gynecologic oncology. His research on high-risk HPV integration and cervical cancer microenvironment analysis has earned recognition in top-tier scientific journals. He has received multiple research grants and academic awards, including funding from the China Scholarship Council for international collaboration. His groundbreaking work on microendoscopic in vivo diagnosis won prestigious innovation awards in medical technology. His contributions to immunotherapy strategies have been acknowledged at international oncology conferences. As a respected leader in gynecologic oncology, he continues to receive honors for his advancements in precision medicine and minimally invasive surgical techniques. His accolades reflect his dedication to improving cancer diagnostics and treatment through innovative research and clinical excellence.

🔬 Research Focus 

📊 Publication Top Notes:

• Ren, X., Zhou, W., Yuan, N., Ruan, Y., & Zhou, H. (2025). Prompt-based polyp segmentation during endoscopy. Medical Image Analysis.

• Niu, S., Kong, D. X., Li, C., Li, F., & Lei, L. (Year not provided). Influence of Hormonal Contraceptive Usage on Risk of Endometriosis.

• Yeshe, P., & Li, F. (2024). Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis. Journal of Radiation Research.

• Xiao, Y., Zhi, Y., Cao, G., Gao, J., & Li, F. (2024). Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature. Journal of Cancer Research and Clinical Oncology.

• Hu, B., Wang, R., Wu, D., Sun, C., & Liao, S. (2024). A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers. Advanced Science.

• Liu, M., Lu, J., Zhi, Y., Gao, J., & Li, F. (2023). Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer. Infectious Agents and Cancer.